XJPX
4409
Market cap110mUSD
Oct 09, Last price
841.00JPY
1D
1.20%
1Q
13.04%
Jan 2017
205.82%
Name
Toho Chemical Industry Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Toho Chemical Industry Company, Limited, established in 1938 and headquartered in Tokyo, Japan, specializes in the global manufacturing and distribution of a diverse array of surfactants, specialty chemicals, resins, and industrial chemicals. The company supplies crucial components across numerous sectors, including daily consumable product industries like cosmetics, toiletries, household cleaning solutions, pulp and paper production, textiles, agricultural pesticides, pharmaceutical formulations, and paints and inks. For civil engineering, construction work, and building material sectors, Toho Chemical offers specialized agents related to concrete and asphalt, along with building material additives and water cutoff chemicals. Their portfolio also encompasses anti-static and anti-fogging agents, emulsifiers for emulsion polymerization, and modifiers, all designed for the plastics industry. Furthermore, they provide essential chemicals for the machinery, transportation equipment, and energy industries, such as brake fluid bases, metalworking fluids, and various energy-related chemical agents. Lastly, Toho Chemical supports the electronic information device materials sector with chemical agents, fine cleaning solutions, solvents for electronic materials, and additives for photocopier toners.
Key people
Mikihito Nagaoka
Managing Director, Manager of Osaka Office, Chief Director of Business, Director of Cosmetic Ingredients Business in Main Business Unit, Chairman and President of Subsidiary · since 2020
Masamoto Wakita
Managing Director, Chief Director of Production · since 2024
Yoshihiro Kubo
Executive Officer, Director of Surfactant Business in Main Business Unit · since 2024
Tomohiro Nomura
Executive Officer, Assistant Manager of Oppama Research Institute in Main Research and Development Unit, Manager of Research and Development Unit · since 2024
Nobuo Takahashi
Executive Officer, Deputy Business Director of Specialty Chemicals Business Unit · since 2024
Shoichi Kawasaki
Chief Director of Accounting, Director · since 2022
Kenichi Nakano
Deputy Chief Director of Research & Development, Director of Oppama Research Institute, Manager of Electron Information Industrial Medicine Research Office, Director · since 2016
Akira Ikeda
Deputy Chief Director in Main Research Development Unit, Director of Chiba Research Institute of Main Research Development Unit, Director · since 2020
Seiichi Koshisaka
Director · since 2024
Tatsuo Nakasaki
President, Chief Executive Officer, Chief Director of Business Planning, Representative Director · since 2016
Haruhisa Shimoda
Deputy Chief Director in Main Business Unit, Director of Specialty Chemical Business in Main Business Unit, Director · since 2020
Independent Director · since 2019
Hiromitsu Kawagoe
Independent Director · since 2022
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||